HCmed Innovations (TPEX:6934) - Stock Price, News & Analysis

6934 Stock Overview

Designs, develops, manufactures, and sells mesh nebulizers to deliver liquid medications into the respiratory airways.

6934 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (NT$2B)

HCmed Innovations Co., Ltd. Competitors

Crystalvue Medical

TPEX:6527

NT$2.3b

BenQ Medical Technology

TPEX:4116

NT$2.3b

Diamond Biotechnology

TPEX:6815

NT$2.4b

Wellell

TWSE:4106

NT$2.6b

Price History & Performance

Summary of all time highs, changes and price drops for HCmed Innovations
Historical stock prices
Current Share Price	NT$80.80
52 Week High	NT$82.80
52 Week Low	NT$64.70
Beta	0
11 Month Change	6.18%
3 Month Change	14.94%
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	13.64%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	6934	TW Medical Equipment	TW Market
7D	3.6%	-0.9%	-0.2%
1Y	n/a	13.8%	32.9%

Return vs Industry: Insufficient data to determine how 6934 performed against the TW Medical Equipment industry.

Return vs Market: Insufficient data to determine how 6934 performed against the TW Market.

Price Volatility

Is 6934's price volatile compared to industry and market?
6934 volatility
6934 Average Weekly Movement	3.5%
Medical Equipment Industry Average Movement	4.8%
Market Average Movement	5.8%
10% most volatile stocks in TW Market	9.3%
10% least volatile stocks in TW Market	3.1%

Stable Share Price: 6934 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 6934's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2014	n/a	Jason Cheng	www.hcmed-inno.com

HCmed Innovations Co., Ltd. designs, develops, manufactures, and sells mesh nebulizers to deliver liquid medications into the respiratory airways. The company’s products include Pulmogine, a vibrating mesh nebulizer to nebulize a range of liquid medications to treat respiratory diseases and their symptoms in children and adults; and AdheResp, a breath-actuated mesh nebulizer for consumers and healthcare professionals. It also provides contract development and manufacturing organization services.

HCmed Innovations Co., Ltd. Fundamentals Summary

How do HCmed Innovations's earnings and revenue compare to its market cap?
6934 fundamental statistics
Market cap	NT$2.43b
Earnings (TTM)	NT$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is 6934 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6934 income statement (TTM)
Revenue	NT$0
Cost of Revenue	NT$0
Gross Profit	NT$0
Other Expenses	NT$0
Earnings	NT$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did 6934 perform over the long term?

See historical performance and comparison